Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Tesaro, Inc.

Clinical trials sponsored by Tesaro, Inc., explained in plain language.

Now part of GSK plc GSK NYSE

Oncology biotech acquired by GSK, known for cancer drug Zejula.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 5 Completed 1 Terminated 1

Ovarian cancer drug trial halted early: what happened?

Disease control Terminated

This study aimed to see if the drug niraparib works better than standard chemotherapy before surgery for people with a specific type of advanced ovarian cancer (stage III or IV with HRd). The trial was planned for 36 participants but was stopped early. Researchers wanted to measu…

Phase: PHASE2 • Sponsor: Tesaro, Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:00 UTC